logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Homology Medicines: Q4 Earnings Snapshot

By AP News - Mar 09, 2023, 05:51 PM ET
Last Updated - Jun 22, 2023, 05:02 PM EDT
Homology Medicines: Q4 Earnings Snapshot

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Homology Medicines Inc. (FIXX) on Thursday reported a loss of $34.3 million in its fourth quarter.

The Bedford, Massachusetts-based company said it had a loss of 60 cents per share.

Sponsored

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

The gene editing company posted revenue of $802,000 in the period.

For the year, the company reported that its loss narrowed to $5 million, or 9 cents per share. Revenue was reported as $3.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a FIXX">Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415